PL1660115T3 - Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwi - Google Patents
Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwiInfo
- Publication number
- PL1660115T3 PL1660115T3 PL04763431T PL04763431T PL1660115T3 PL 1660115 T3 PL1660115 T3 PL 1660115T3 PL 04763431 T PL04763431 T PL 04763431T PL 04763431 T PL04763431 T PL 04763431T PL 1660115 T3 PL1660115 T3 PL 1660115T3
- Authority
- PL
- Poland
- Prior art keywords
- csf
- useful
- plgf
- blood stem
- stem cell
- Prior art date
Links
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 210000000130 stem cell Anatomy 0.000 title abstract 2
- 101150062285 PGF gene Proteins 0.000 title 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03017174 | 2003-07-29 | ||
| EP04763431A EP1660115B1 (en) | 2003-07-29 | 2004-07-23 | Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
| PCT/EP2004/008245 WO2005014023A1 (en) | 2003-07-29 | 2004-07-23 | Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1660115T3 true PL1660115T3 (pl) | 2011-11-30 |
Family
ID=34130041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04763431T PL1660115T3 (pl) | 2003-07-29 | 2004-07-23 | Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwi |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20070036747A1 (pl) |
| EP (1) | EP1660115B1 (pl) |
| JP (1) | JP4855253B2 (pl) |
| KR (1) | KR101192136B1 (pl) |
| CN (1) | CN100534528C (pl) |
| AT (1) | ATE513555T1 (pl) |
| AU (1) | AU2004262909B2 (pl) |
| BR (1) | BRPI0412989A (pl) |
| CA (1) | CA2526244C (pl) |
| DK (1) | DK1660115T3 (pl) |
| ES (1) | ES2369487T3 (pl) |
| IL (1) | IL173369A (pl) |
| MX (1) | MXPA06000017A (pl) |
| NO (1) | NO20060955L (pl) |
| NZ (1) | NZ543612A (pl) |
| PL (1) | PL1660115T3 (pl) |
| PT (1) | PT1660115E (pl) |
| RU (1) | RU2351357C2 (pl) |
| SI (1) | SI1660115T1 (pl) |
| WO (1) | WO2005014023A1 (pl) |
| ZA (1) | ZA200509361B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2206719E (pt) | 2005-03-02 | 2015-02-05 | Univ Maryland | Composição farmacêutica compreendendo 3-beta-hidroxi-17- (1-h-benzimidazol-1-il)androsta-5,16-dieno |
| US20100048524A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| GB2470700B (en) | 2008-03-25 | 2012-08-08 | Univ Maryland | C-17 heteroaryl steroidal CYP17 inhibitors |
| US8785423B2 (en) | 2008-04-14 | 2014-07-22 | University Of Maryland, Baltimore | Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
| WO2010091306A1 (en) | 2009-02-05 | 2010-08-12 | Tokai Pharmaceuticals | Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| US8791095B2 (en) | 2009-02-05 | 2014-07-29 | Tokai Pharmaceuticals, Inc. | Steroidal CYP17 inhibitors/antiandrogens |
| BR112012002797A2 (pt) | 2009-08-07 | 2019-09-24 | Tokai Pharmaceuticals Inc | tratamento de câncer de próstata |
| KR20160023638A (ko) | 2013-02-28 | 2016-03-03 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 줄기세포를 이동하기 위한 방법 및 조성물 |
| EP2968370A4 (en) | 2013-03-14 | 2016-09-21 | Univ Maryland | AGENT FOR ANDROGEN RECEPTOR DOWNWARD CONTROL AND USES THEREOF |
| EP3033088A4 (en) | 2013-08-12 | 2017-03-08 | Tokai Pharmaceuticals, Inc. | Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies |
| LT6161B (lt) | 2013-09-27 | 2015-06-25 | Uab Profarma | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas |
| CN114891746A (zh) * | 2021-12-21 | 2022-08-12 | 青岛今墨堂生物技术有限公司 | 一种犬全血造血干细胞的制备方法 |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
| DE19549232C2 (de) * | 1995-12-20 | 1998-05-20 | Boehringer Mannheim Gmbh | Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern |
| US7105168B1 (en) * | 2002-06-04 | 2006-09-12 | D. Collen Research Foundation Vzw | Method of improving ischemic muscle function by administering placental growth factor |
| EP1147777A1 (en) * | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
| KR20030034177A (ko) * | 2000-09-13 | 2003-05-01 | 쥬가이 세이야쿠 가부시키가이샤 | 허혈성 질환 치료제 |
| DE10234192B4 (de) * | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
| EP1594527A2 (en) * | 2003-02-04 | 2005-11-16 | Ludwig Institute For Cancer Research | Vegf-b and pdgf modulation of stem cells |
-
2004
- 2004-07-23 WO PCT/EP2004/008245 patent/WO2005014023A1/en not_active Ceased
- 2004-07-23 SI SI200431743T patent/SI1660115T1/sl unknown
- 2004-07-23 AU AU2004262909A patent/AU2004262909B2/en not_active Ceased
- 2004-07-23 AT AT04763431T patent/ATE513555T1/de active
- 2004-07-23 KR KR1020057023606A patent/KR101192136B1/ko not_active Expired - Fee Related
- 2004-07-23 MX MXPA06000017A patent/MXPA06000017A/es active IP Right Grant
- 2004-07-23 RU RU2006106228/15A patent/RU2351357C2/ru not_active IP Right Cessation
- 2004-07-23 EP EP04763431A patent/EP1660115B1/en not_active Expired - Lifetime
- 2004-07-23 BR BRPI0412989-0A patent/BRPI0412989A/pt not_active IP Right Cessation
- 2004-07-23 PT PT04763431T patent/PT1660115E/pt unknown
- 2004-07-23 PL PL04763431T patent/PL1660115T3/pl unknown
- 2004-07-23 DK DK04763431.6T patent/DK1660115T3/da active
- 2004-07-23 ES ES04763431T patent/ES2369487T3/es not_active Expired - Lifetime
- 2004-07-23 NZ NZ543612A patent/NZ543612A/en not_active IP Right Cessation
- 2004-07-23 ZA ZA200509361A patent/ZA200509361B/en unknown
- 2004-07-23 JP JP2006521487A patent/JP4855253B2/ja not_active Expired - Fee Related
- 2004-07-23 CN CNB2004800213159A patent/CN100534528C/zh not_active Expired - Fee Related
- 2004-07-23 US US10/565,903 patent/US20070036747A1/en not_active Abandoned
- 2004-07-23 CA CA2526244A patent/CA2526244C/en not_active Expired - Fee Related
-
2006
- 2006-01-26 IL IL173369A patent/IL173369A/en not_active IP Right Cessation
- 2006-02-27 NO NO20060955A patent/NO20060955L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06000017A (es) | 2006-03-21 |
| JP2007500157A (ja) | 2007-01-11 |
| ZA200509361B (en) | 2007-03-28 |
| RU2006106228A (ru) | 2007-09-10 |
| NZ543612A (en) | 2008-03-28 |
| KR20060079753A (ko) | 2006-07-06 |
| CN1826134A (zh) | 2006-08-30 |
| NO20060955L (no) | 2006-02-27 |
| DK1660115T3 (da) | 2011-10-10 |
| IL173369A (en) | 2010-12-30 |
| ES2369487T3 (es) | 2011-12-01 |
| SI1660115T1 (sl) | 2011-10-28 |
| EP1660115A1 (en) | 2006-05-31 |
| BRPI0412989A (pt) | 2006-10-03 |
| EP1660115B1 (en) | 2011-06-22 |
| JP4855253B2 (ja) | 2012-01-18 |
| AU2004262909A1 (en) | 2005-02-17 |
| RU2351357C2 (ru) | 2009-04-10 |
| CA2526244A1 (en) | 2005-02-17 |
| WO2005014023A1 (en) | 2005-02-17 |
| KR101192136B1 (ko) | 2012-10-16 |
| PT1660115E (pt) | 2011-08-24 |
| CN100534528C (zh) | 2009-09-02 |
| CA2526244C (en) | 2012-03-20 |
| AU2004262909B2 (en) | 2010-07-01 |
| US20070036747A1 (en) | 2007-02-15 |
| ATE513555T1 (de) | 2011-07-15 |
| IL173369A0 (en) | 2006-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173369A0 (en) | Pharmaceutical combination of g-csf and plgf useful for blood stem cell | |
| WO2005021706A3 (en) | Delivery of compounds with rehydrated blood cells | |
| IL171683A (en) | Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment | |
| NO20063430L (no) | Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering | |
| AU2002359340A1 (en) | Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo | |
| WO2005025615A3 (en) | FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY | |
| WO2004011611A3 (en) | Taci antibodies and uses thereof | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| WO2007073518A3 (en) | Compounds and methods for thiol-containing compound efflux and cancer treatment | |
| AU2002243005A1 (en) | Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods | |
| WO2006078782A3 (en) | Compositions containing agm cells and methods of use thereof | |
| EP2177531A3 (en) | Cell permeable peptide | |
| GR20020100478A (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
| WO2003079967A3 (en) | Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue | |
| WO2007008232A3 (en) | Locoregional internal radionuclide ablation of abnormal tissues. | |
| GEP20074075B (en) | Indazolamides with analgesic activity | |
| FR2883184B1 (fr) | Composition de spirulines riche en principes actifs, procede d'obtention et utilisation | |
| WO2004087876A3 (en) | Use of red blood cells to facilitate cell activation | |
| PL1663101T3 (pl) | Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie | |
| WO2004087117A3 (de) | Verwendung von cyclischen aketalen/ketalen zur verbesserten penetration von wirkstoffen in zellen und organen | |
| PL1668021T3 (pl) | Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie | |
| WO2008107785A3 (en) | Composition containing autologous mononuclear cells and scaffold and its use in the preparation of a surgical medicament | |
| HUP0203277A2 (en) | Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation | |
| NO20071096L (no) | Diarylmetylpiperazinderivater, fremstillinger derav og anvendelser derav |